Even as the clinical community works to establish the long-term benefits of current GLP-1 and HRT combinations, a new generation of metabolic therapies is already moving through trials, ones that extend the biological logic of this article's central argument into territory that semaglutide and tirzepatide alone cannot reach
Telomere-length changes were reported in cell cultures
EOLA1 protects lipopolysaccharide induced IL-6 production and apoptosis by regulation of MT2A in human umbilical vein endothelial cells
Phentermine delivers faster initial results by stimulating norepinephrine release in the brain, which curbs hunger quickly
2,3,4 These improvements are seen whether LEGEND is administered by intravenous (I.V.) or intra-articular (I.A.) injection
Advanced qPCR Technology: The Complete Microbiome Panel utilizes quantitative polymerase chain reaction technology to assess the quantity and diversity of good bacteria as well as gut inflammation and dysbiosis